Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Long-acting naltrexone reduces heavy drinking in alcohol-dependent subjects

April 13, 2005

Alkermes submits Vivitrex NDA

April 6, 2005

Hemosol to produce iron-binding drugs for Biomedical Frontiers

April 6, 2005

New title added to Drug R&D Backgrounders series: Nicotine Addiction

March 30, 2005

CB1 antagonist prevents relapsing to heroin seeking in rats

March 17, 2005

Varenicline reported to increase smoking cessation

March 8, 2005

Preliminary phase I data on the efficacy of TA-NIC in nicotine addiction

March 7, 2005

Dopamine transporter ligand identified with potential efficacy as a treatment for cocaine addiction

March 3, 2005

Evidence supports the use of nicotine replacement therapies in heavy smokers

March 2, 2005

Somaxon licenses rights for oral nalmefene for nicotine dependence

Feb. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...